Terms: = Breast cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Clinical Outcome
9 results:
1. Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse.
Sanchez-Spitman AB; Swen JJ; Dezentjé VO; Moes DJAR; Gelderblom H; Guchelaar HJ
Sci Rep; 2021 Jan; 11(1):415. PubMed ID: 33432065
[TBL] [Abstract] [Full Text] [Related]
2. Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities.
Pancholi S; Ribas R; Simigdala N; Schuster E; Nikitorowicz-Buniak J; Ressa A; Gao Q; Leal MF; Bhamra A; Thornhill A; Morisset L; Montaudon E; Sourd L; Fitzpatrick M; Altelaar M; Johnston SR; Marangoni E; Dowsett M; Martin LA
Oncogene; 2020 Jun; 39(25):4781-4797. PubMed ID: 32307447
[TBL] [Abstract] [Full Text] [Related]
3. A Multi-million Mammography Image Dataset and Population-Based Screening Cohort for the Training and Evaluation of Deep Neural Networks-the Cohort of Screen-Aged Women (CSAW).
Dembrower K; Lindholm P; Strand F
J Digit Imaging; 2020 Apr; 33(2):408-413. PubMed ID: 31520277
[TBL] [Abstract] [Full Text] [Related]
4. Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.
Milea A; George SH; Matevski D; Jiang H; Madunic M; Berman HK; Gauthier ML; Gallie B; Shaw PA
Mod Pathol; 2014 Jul; 27(7):991-1001. PubMed ID: 24336157
[TBL] [Abstract] [Full Text] [Related]
5. MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.
Zhao Y; Li Y; Lou G; Zhao L; Xu Z; Zhang Y; He F
PLoS One; 2012; 7(6):e39102. PubMed ID: 22723937
[TBL] [Abstract] [Full Text] [Related]
6. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures.
Zhou L; Jiang Y; Yan T; Di G; Shen Z; Shao Z; Lu J
Breast Cancer Res Treat; 2010 Aug; 122(3):795-801. PubMed ID: 20571867
[TBL] [Abstract] [Full Text] [Related]
7. A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.
Bax DA; Mackay A; Little SE; Carvalho D; Viana-Pereira M; Tamber N; Grigoriadis AE; Ashworth A; Reis RM; Ellison DW; Al-Sarraj S; Hargrave D; Jones C
Clin Cancer Res; 2010 Jul; 16(13):3368-77. PubMed ID: 20570930
[TBL] [Abstract] [Full Text] [Related]
8. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
[TBL] [Abstract] [Full Text] [Related]
9. Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.
Desmedt C; Ouriaghli FE; Durbecq V; Soree A; Colozza MA; Azambuja E; Paesmans M; Larsimont D; Buyse M; Harris A; Piccart M; Martiat P; Sotiriou C
Int J Cancer; 2006 Dec; 119(11):2539-45. PubMed ID: 16929516
[TBL] [Abstract] [Full Text] [Related]
